In a topical MC903 application model, basophil-derived IL-4 acts on skin-resident group 2 innate lymphoid cells (ILC2s), leading to enhanced proliferation of ILC2s and AD-like skin inflammation (42). This evidence concerns the gene IL4 and dermatitis.